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ABSTRACT
Objectives: This study aims to identify patient and
treatment factors that the effect clinical outcome of
community psychological therapy through the
development of a predictive model using historic data
from 2 services in London. In addition, the study aims
to assess the completeness of data collection, explore
how treatment outcomes are discriminated using
current criteria for classifying recovery, and assess the
feasibility and need for undertaking a future larger
population analysis.
Design: Observational, retrospective discriminant
analysis.
Setting: 2 London community mental health services
that provide psychological therapies for common
mental disorders including anxiety and depression.
Participants: A total of 7388 patients attended the
services between February 2009 and May 2012, of
which 4393 (59%) completed therapy, or there was an
agreement to end therapy, and were included in the
study.
Primary and secondary outcome measures:
Different combinations of the clinical outcome scores
for anxiety Generalised Anxiety Disorder-7 and
depression Patient Health Questionnaire-9 were used to
construct different treatment outcomes.
Results: The predictive models were able to assign a
positive or negative clinical outcome to each patient
based on 5 independent pre-treatment variables, with
an accuracy of 69.4% and 79.3%, respectively: initial
severity of anxiety and depression, ethnicity,
deprivation and gender. The number of sessions
attended/missed were also important factors identified
in recovery.
Conclusions: Predicting whether patients are likely to
have a positive outcome following treatment at entry
might allow suitable modification of scheduled
treatment, possibly resulting in improvements in
outcomes. The model also highlights factors not only
associated with poorer outcomes but inextricably
linked to prevalence of common mental disorders,
emphasising the importance of social determinants not
only in poor health but also poor recovery.
INTRODUCTION
The Improving Access to Psychological
Therapies (IAPT) programme was launched
in England in 2007 to provide community-
based services for the treatment of people
with common mental disorders (CMDs),
including anxiety and depression.1 The
national programme supports the delivery of
locally tailored psychological services, provid-
ing access to evidence-based psychological
therapies, including those based on a
Strengths and limitations of this study
▪ This article presents novel research exploring the
effects of patient and treatment factors on the
clinical outcomes of patients receiving psycho-
logical therapies as treatment for common
mental disorders.
▪ The research has been developed with clinicians
to contextualise and potentially apply findings to
improve clinical outcomes of patients as an
example of translational research.
▪ Assessing the likelihood of a patient to achieve a
positive outcome at assessment may offer an
opportunity to modulate/augment treatment or
provide additional support to ensure the best
possible outcome for the patient.
▪ While the sample size was sufficiently large to
investigate the variables included in the study,
the sample was not large enough to permit
important subgroup analyses that could elucidate
differences within ethnic groups, which are
known to differ markedly in respect to common
mental health problems, or possible interactions
between different variables.
▪ Exclusion of patients who did not complete treat-
ment was necessary to analyse treatment out-
comes, but represents a significant proportion of
those who entered the service. More needs to be
done to understand the characteristics and
underlying reasons for non-completion.
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cognitive–behavioural therapy (CBT) approach, as
recommended by national guidelines.2 3 There is some
evidence of increased prevalence of CMDs in certain
populations including those living in areas of high socio-
economic deprivation, some members of Black and
Minority Ethnic (BME) communities, forced migrants
and asylum seekers.4–6 Inequalities seen in these popula-
tions are often exacerbated by inequities in access to
appropriate services, highlighting the need for speciﬁc
strategies to improve access for these groups.6–8
The IAPT programme established a minimum data set
for the routine collection of data including demograph-
ics, such as age, ethnicity, gender and residential post-
code; information from patient interactions with the
service, including treatment type/intensity and sessions
attended or missed.9 Clinical outcomes were assessed
using the Patient Health Questionnaire-9 (PHQ-9) and
Generalised Anxiety Disorder-7 (GAD-7) tools, adminis-
tered before and after treatment.10 11 The values of
PHQ-9 and GAD-7 at entry determine a patient’s ‘case-
ness’ or severity of depression or anxiety, respectively,
which is the stated but not mandatory level for entry to
IAPT (PHQ-9 >10 and GAD-7 >8). These measures are
subsequently used to assess a positive response (recov-
ery) following treatment, and is deﬁned as those that
have a PHQ-9 ≤10 and GAD-7 ≤8.12
These data have allowed periodical analyses and evalua-
tions of the delivery of IAPT, including a report in 2012
that analysed data on the ﬁrst 1 000 000 people referred
to the service nationally.13 The report concluded that the
IAPT programme had provided people with access to
evidence-based psychological therapies that they would
not have previously accessed, and recovery rates of those
treated (45%) were of similar magnitude to those seen in
randomised controlled trials (50%), much of which
could only be demonstrated through the complete and
rigorous collection of key outcome measures.
Future developments of the programme include
expansion of current services to speciﬁcally address the
needs of those with long-term conditions and medically
unexplained symptoms, and the development of new
services to support children and young people, and
those with a severe and enduring mental illness.13
Despite the apparent success of the programme, there
is heterogeneity in treatment outcomes, with little evi-
dence of what works for whom. A better understanding
of characteristics associated with speciﬁc outcomes and
the ability to predict the likelihood of patients achieving
a positive outcome may offer an opportunity to provide
more individualised treatment, and improve outcomes
for all those who access the service.
This paper aims to identify patient and treatment
factors that affect clinical outcome of community psy-
chological therapy through the development of a pre-
dictive model using historic data from two IAPT services
in London. In addition, the paper aims to assess the
completeness of data collection, explore how treatment
outcomes are discriminated using current criteria for
classifying recovery using the predictive model, and
assess the feasibility and need for undertaking a future
larger population analysis.
METHOD
Ethical approval
Ethics approval was not required for this work as the
clinical team providing care for patients anonymised all
data routinely collected for clinical purposes, prior to
transferring the data to researchers for analysis (in
accordance with UK Governance Arrangements for
Research Ethics Committees, Section C4). The research
study was registered with Chelsea and Westminster NHS
Foundation Trust.
Study setting
The anonymised data was extracted from two
community-based IAPT services that serve two different
London boroughs. Service A, launched in 2009,
included a team of 30 therapists, serving a population of
more than 200 000 people, where more than 30% of the
local population is from a BME background, and under
60% of the working age population is employed. Service
B, established in 2010, comprised a team of 15 therapists
serving a population of nearly 300 000 people, of which
up to 60% come from a BME background, and over
60% of the working age population is employed. Both
boroughs include signiﬁcant pockets of severe depriv-
ation within the top 5% in UK.
Data sources/sample and exclusion criteria
Data for all referrals to the services between February
2009 and May 2012 were collected by the IAPT clinical
team using IAPTus (Mayden, Wiltshire, UK), a clinical
data system. Data included independent and dependent
variables, as described below, collected as part of the
minimum dataset, collected at two time points, during
the ﬁrst session (pre-treatment) and at the ﬁnal session
(post-treatment).9
To maintain anonymity, the clinical team converted
postcode to Index of Multiple Deprivation (IMD) prior to
transferring the data to researchers. Only cases with
values for both ﬁnal scores of PHQ-9 and GAD-7 were
included in the analyses, as both were required for gen-
erating the outcome measures.
Patients assigned inappropriate values for age or length
of treatment (ie, age <0 or >105; length of treatment >14 000
days—a value created by the database to indicate those
where no start was indicated, as no length of treatment
could be calculated) were removed from analysis. Data
were imported into SPSS (IBM SPSS Statistics V.21), and
where necessary, variables were converted from alpha-
numeric to numeric or coded data.
Independent variables
Independent variables were selected on the basis of
availability within the data set and were classiﬁed
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according to the temporal collection of data, that is, ﬁrst
session (pre-treatment) or ﬁnal session (post-
treatment). Pre-treatment included: gender [Male/Female],
age [1–105], ethnicity [White-British/BME/Not stated], able to
communicate in spoken English [Yes/No], understand written
English [Yes/No], source of referral [GP/self-referral],
PHQ-9 ﬁrst score [0–27] and GAD-7 ﬁrst score [0–21] and
postcode converted to Index of Multiple Deprivation (IMD)
[1–70]. The values for the PHQ-9 ﬁrst score and GAD-7
ﬁrst score were checked for ‘caseness’ that is, PHQ-9 >10
and GAD-7 >8. Post-treatment variables included: number
of sessions not attended (DNA), number of sessions attended,
length of treatment [Days], reason for end of IAPT care
pathway [planned ending/deceased/declined further
contact/dropped out/ineligible for service/signposted/
no treatment indicated], Guided Self-Help [Yes/No] and
high-intensity treatment (Cognitive Behaviour Therapy)
[Yes/No].
Outcome measures
Severity of anxiety and depression was assessed during
the ﬁnal treatment session using the GAD-7 tool and the
PHQ-9 tool, respectively. The scores generated repre-
sented the dependent post-treatment variables GAD-7
ﬁnal score and PHQ-9 ﬁnal score.
These variables were used to allocate patients to a new
categorical outcome variable, Treatment Outcome. GAD-7
ﬁnal score less than eight and PHQ-9 ﬁnal score less than
10 indicate positive outcomes, while scores ≥8 or ≥10,
respectively, indicate negative outcomes.
This resulted in four treatment outcome options, P1P2,
P1N2, N1P2 and N1N2, depending on whether either or
both outcomes were positive (P) or negative (N), for
example, those achieving a PHQ-9 <10 (P1) and GAD-7
<8 (P2) were allocated to the P1P2 Treatment Outcome,
as shown in table 1.
Outcome group
Further to establishing an outcome measure for the
study, these were further classiﬁed to create outcome
groups, to allow separate analysis of the current
approaches to classifying recovery. The analysis was based
on Treatment Outcomes, testing P1P2 against N1N2
(Outcome Group 1), P1P2 against P1N2, N1P2 and
N1N2 combined (Outcome Group 2) and P1P2 versus
P1N2 versus N1P2 versus N1N2 (Outcome Group 3). The
data cleaning and allocation to outcome groups is out-
lined in ﬁgure 1.
Assessing completeness of data and a comparison
of data sets
Frequencies were calculated for the categorical data
and descriptive statistics (mean, SD, minimum and
maximum) for the numerical variables from each service.
Descriptive statistics for the numerical variables were cal-
culated for the combined data, classiﬁed by Treatment
Outcome: P1P2, P1N2, N1P2 and N1N2. The non-
parametric independent samples Kruskal-Wallis test (K-W
test), and the univariate Analysis of Variance (univariate
ANOVA) procedure were used to check for any differ-
ences in the variables: Age, Number of sessions not attended
(DNA), Number of sessions attended, Length of Treatment,
PHQ9 ﬁrst score, GAD7 ﬁrst score and IMD, comparing the
four Treatment Outcomes. The post hoc test, Tukey’s
honestly signiﬁcant difference was used to identify any
signiﬁcant differences between the outcome groups.14
Identifying predictors and developing a predictive model
The statistical procedure used for both the prediction of
treatment outcome and also to identify which variables
contributed to a positive treatment outcome was Classify
by means of Discriminant Analysis.15 16 This procedure
builds a predictive model for group membership. The
model is composed of a discriminant function (or, for
more than two groups, a set of discriminant functions)
based on linear combinations of the predictor variables
that provide the best discrimination between the groups.
For the initial calculations, the functions were generated
from a sample of randomly selected cases for which
group membership was known; the functions could then
be tested on the unselected cases with known group
membership. If the functions produced correct predic-
tions for 60% or above, the model was accepted as suit-
able for the predicting cases with unknown group
membership.
The grouping variable can have more than two values.
The codes for the grouping variable must be integers,
and it was necessary to specify the respective minimum
and maximum values. Patients with values outside of
these bounds were excluded from the analysis. The tests
of equality of group means, Wilks’ λ and the signiﬁcance
test, were used to identify the relative contribution of
each variable to the models; the lower the value of
Wilks’ λ, the greater the contribution to the model.
Discriminant Analysis using only the pre-treatment
variables known was used in order to test the possibility
of assessing whether a patient would have a positive or
negative response to the standard treatment schedule.
The same statistical procedure, using variables known at
the completion of treatment (pre-treatment and post-
treatment variable), was used to identify which variables
Table 1 Classification of treatment outcome combining
final values of PHQ-9 and GAD-7
Treatment
outcome
Final PHQ-9 Final GAD-7
<10 ≥10 <8 ≥8
P1P2 Positive Positive
P1N2 Positive Negative
N1P2 Negative Positive
N1N2 Negative Negative
GAD-7, Generalised Anxiety Disorder-7; N1P2, negative PHQ-9,
positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; PHQ-9,
Patient Health Questionnaire-9; P1P2, positive PHQ-9, positive
GAD-7; P1N2, positive PHQ-9, negative GAD-7.
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contributed to the models, and were therefore inﬂuen-
cing whether a patient had a positive or negative
Treatment Outcome.
In order to test whether the model produced by
Discriminant Analysis was consistent for different ser-
vices, Services A and B were each used to classify both
services. The results were then compared to check the
percentage of cases with identical classiﬁcations.
RESULTS
Assessing completeness of data and a comparison
of data sets
The frequencies for the categorical variables for Services
A and B are shown in table 2. The analysis demonstrated
some interesting results especially relating to the propor-
tions of patients with a BME background attending the
services, (A=50%, B=63%) compared with white British
Figure 1 Flow diagram showing the organisation of procedures and the number of patients included at each stage of data
cleaning and allocation of patients to outcome groups (GAD-7, Generalised Anxiety Disorder-7; IAPT, Improving Access to
Psychological Therapies; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; PHQ-9, Patient
Health Questionnaire-9; P1P2, positive PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7).
Table 2 Frequencies of categorical variables comparing services A and B
Variable
Completeness of
data recording (%)
Service A Service B
N (%) N (%)
Gender
M:F
100 1098:2061 (35:65) 445:787 (36:64)
Ethnicity
White British: BME: not stated
93 1292:1438:131 (45:50:5) 361:776:95 (29:63:8)
Able to communicate in spoken English?
Yes:No:Don’t know
91 2828:39:32 (98.3:0.9:0.9) 1048:39:18 (94.8:3.5:1.6)
Understand written English?
Yes:No:Don’t know
90 2828:39:32 (97.6:1.3:1.1) 972:43:43 (91.9:4.1:4.1)
Source of Referral
GP:Self:Other
100 2268:656:236 (71.8:20.8:7.5) 1157:2:73 (93.9:0.2:5.9)
Caseness threshold met
Yes:No
100 2130:1029 (67.4:32.6) 885:347 (71.8:28.2)
GSH
Yes:No
100 2110:1050 (66.8:33.2) 455:777 (36.9:63.1)
CBT
Y:N
100 1651:1509 (52.2:47.8) 822:410 (66.7:33.3)
BME, black and minority ethnic; CBT, cognitive–behavioural therapy; GSH, guided self-help.
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patients (A=45%, B=29%). Patients attending Service B
were less likely to have entered the GSH programme
(A=66.8%, B=36.9%) and more likely to have had CBT
(A=52.2%, B=66.7%) than patients from Service A. More
patients attending Service A were self-referred (A=20.8%
B=0.2%), while the majority of patients attending
Service B were GP referred (A=71.8%, B=93.9%). There
did not appear to be any difference between the two
Services with regard to the ratio of males to females,
ability to communicate in spoken English, and to under-
stand written English. The percentage of patients
assessed to be ‘case’ at admission was similar in both
Services (A=67.4%, B=71.8%).
The descriptive statistics for the numeric variables for
Services A and B are shown in table 3. Apart from the age
range of the patients, and ﬁrst and last PHQ-9/GAD-7
scores, which were similar for both Services, the values of
variables for Service B tended to be numerically lower
than those for Service A, although the ranges were similar.
The descriptive statistics for the numeric variables by
Treatment Outcome are shown in table 4. Although the
age ranges are similar, there is a slight increase in the
mean ages from the positive to the negative Treatment
Outcome. The entry scores for PHQ-9 and GAD-7 are
both lower for the patients with a positive, compared
with negative Treatment Outcome.
Identifying predictors and developing a predictive model
Are there sufficient differences between the treatment
outcomes?
The K-W test showed that the distribution of variables
known at initial enrolment including PHQ-9/GAD-7
scores, Age and IMD, were not the same across the
categories of Treatment Outcome. The distribution of
post-treatment variables including length of treatment,
number of sessions attended and DNA were also shown
to be different. OneWay ANOVA and the Tukey’s HND
test were used to identify the differences within the pre-
treatment and post-treatment variables, as a substitute
for the Student-Newman-Keuls procedure (table 5).17
These results suggested that there were sufﬁcient differ-
ences between the positive and negative Treatment
Outcomes to enable the Discriminant Analysis to differ-
entiate between them. The table also demonstrates the
contribution of numerical direction of variables that is,
high values for PHQ-9/GAD-7 ﬁrst scores, IMD, are asso-
ciated with poorer outcomes (4th column, highest value
shows N1N2), while a high value for number of sessions
attended indicates a positive outcome (4th column
highest value shows P1P2).
Outcome group 1: can positive and negative treatment
outcomes be predicted from pre-treatment variables?
Discriminant Analyses for Outcome Group 1 data (dif-
ferentiate between P1P2 and N1N2) using nine pre-
treatment variables: gender, age, ethnicity, caseness achieved,
understand written English, source of referral, PHQ-9 ﬁrst
score, GAD-7 ﬁrst score and IMD showed that the
Treatment Outcome (P1P2, N1N2) could be correctly
predicted for between 69.9–76% of cases, table 6.
Classiﬁcation of the selected grouped cases (ie, cases
with known Treatment Outcome used to calculate the
model) was correct for 71.8%, and for the unselected
original grouped cases (ie, cases with known Treatment
Outcome not used to calculate, but to test the model)
was 74.9% correct. The classiﬁcations of the selected
Table 3 Descriptive statistics for numeric variables for services A and B
Completeness of
data recording (%) Service n Minimum Maximum Mean SD
Age 100 A 3159 17 100 38.3 13.3
B 1232 12 95 38.2 12.7
Length of treatment (days) 100 A 3160 0 571 104.5 86.1
B 1232 0 409 96.6 79.0
DNA sessions (n) 100 A 3160 0 12 0.71 1.2
B 1232 0 9 0.8 1.2
Attended sessions (n) 100 A 3160 1 33 7.5 5.4
B 1232 1 30 6.5 4.6
PHQ9 first score 100 A 3160 0 27 14.3 6.5
B 1232 0 27 15.4 6.8
PHQ9 last score 100 A 3160 0 27 9.2 6.9
B 1232 0 27 10.9 7.4
GAD-7 first score 100 A 3158 0 21 12.6 5.6
B 1232 0 21 13.4 5.5
GAD-7 last score 100 A 3160 0 21 8.3 6.0
B 1232 0 21 9.7 6.2
IMD 98.2 A 3095 1.4 69.7 27.1 12.6
B 1221 9.7 61.4 29.9 11.2
DNA, sessions not attended; GAD-7, Generalised Anxiety Disorder-7; IMD, Index of Multiple Deprivation; PHQ9, Patient Health
Questionnaire-9.
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cases were also tested by cross-validation, where each
case was classiﬁed by the functions derived from all cases
other than that case, which showed that 71.6% of these
classiﬁcations were correct.
The contribution of each variable to the model is
shown in table 7; all the variables entered contributed to
the model, but PHQ-9 ﬁrst score and GAD-7 ﬁrst score were
the most important, followed by caseness achieved, IMD
and ethnicity.
Outcome group 2: can positive and negative (including
partial) treatment outcomes be predicted from pre-treatment
variables?
Discriminant Analyses for Outcome Group 2 data (dif-
ferentiate between P1P2 and all negative Treatment
Outcomes, P1N2, N1P2 and N1N2 merged) using nine
pre-treatment variables: gender, age, ethnicity, caseness
achieved, understand written English, source of referral, PHQ-9
ﬁrst score, GAD-7 ﬁrst score and IMD showed that
Table 4 Descriptive statistics for numeric variables for each treatment outcome
Pre-treatment/post-
treatment variable Variable
Treatment
outcome n Minimum Maximum Mean SD
Pre-treatment Age P1P2 2001 17 86 37.86 13.36
P1N2 440 18 88 36.67 13.42
N1P2 222 17 83 40.17 14.97
N1N2 1728 12 100 38.92 12.51
Pre-treatment PHQ9 1st score P1P2 2001 0 27 11.7 6.3
P1N2 440 1 27 13.0 5.8
N1P2 222 0 27 15.9 5.3
N1N2 1729 0 27 18.3 5.3
Pre-treatment GAD-7 1st score P1P2 2000 0 21 10.6 5.5
P1N2 439 0 21 13.6 4.7
N1P2 222 0 21 11.1 5.4
N1N2 1729 0 21 15.6 4.4
Pre-treatment IMD P1P2 1971 1.4 61.4 26.39 11.72
P1N2 426 2.4 61.4 26.69 12.04
N1P2 217 4.0 61.4 27.38 12.79
N1N2 1702 3.1 69.7 29.94 12.66
Post-treatment Length of treatment
(days)
P1P2 1825 3 571 121.64 78.15
P1N2 371 5 510 130.18 91.35
N1P2 196 1 454 108.57 80.67
N1N2 1448 1 482 108.94 79.06
Post-treatment Number of sessions
not attended
P1P2 2001 0 9 0.55 0.98
P1N2 440 0 7 0.66 1.07
N1P2 222 0 6 0.85 1.11
N1N2 1729 0 12 0.97 1.31
Post-treatment Number of sessions
attended
P1P2 2001 1 32 8.01 5.13
P1N2 440 1 32 7.14 5.54
N1P2 222 1 28 6.19 4.76
N1N2 1729 1 33 6.41 5.18
GAD-7, Generalised Anxiety Disorder-7; IMD, Index of Multiple Deprivation; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9,
negative GAD-7; P1P2, positive PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.
Table 5 Grading from lowest to highest numerical levels for pre-treatment and post-treatment variables
Pre-treatment/post-
treatment variable Variable
Grading in order from lowest to highest level
1st 2nd 3rd 4th
Pre-treatment Age P1N2 P1P2 N1N2 N1P2
Pre-treatment PHQ-9 1st score P1P2 P1N2 N1P2 N1N2
Pre-treatment GAD-7 1st score P1P2 N1P2 P1N2 N1N2
Pre-treatment IMD P1P2 P1N2 N1P2 N1N2
Post-treatment LoT (days) N1P2 N1N2 P1P2 P1N2
Post-treatment Number of DNA sessions P1P2 P1N2 N1P2 N1N2
Post-treatment Number of Attended sessions N1P2 N1N2 P1N2 P1P2
GAD7, Generalised Anxiety Disorder-7; IMD, Index of Multiple Deprivation; LoT, length of treatment; N1P2, negative PHQ-9, positive GAD-7;
N1N2, negative PHQ-9, negative GAD-7; P1P2, positive PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient
Health Questionnaire-9.
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Treatment Outcome (P1P2, Negative) could be correctly
predicted for between 66.8% and 71.0% of cases,
table 8. Classiﬁcation of the selected grouped cases was
correct for 68.5%, and for the unselected original
grouped cases it was 70.9% correct. The classiﬁcations of
the selected cases tested by cross-validation showed that
68.3% of these classiﬁcations were correct.
The contribution of each variable to the model is
shown in table 9; seven of the variables entered contrib-
uted to the model, caseness achieved and source of referral
were omitted. PHQ-9 ﬁrst score and GAD-7 ﬁrst score were
the most important, followed by IMD and ethnicity.
Outcome group 2: can positive and negative (including
partial) treatment outcomes be predicted from pre-treatment
and post-treatment variables?
Discriminant Analyses for Outcome Group 2 data
(differentiate between P1P2 and all negative Treatment
Outcomes, P1N2, N1P2 and N1N2 merged) using 14
pre-treatment and post-treatment variables: gender, age,
ethnicity, understand written English, source of referral, PHQ-9
ﬁrst score, GAD-7 ﬁrst score, IMD, length of treatment, number
of sessions not attended (DNA), number of sessions attended,
reason for end of IAPT care pathway, Guided Self-Help and
high intensity treatment, showed that Treatment Outcome
(P1P2, Negative) could be correctly predicted for
between 66.8% and 71.0% of cases, table 10.
Classiﬁcation of the selected grouped cases was correct
for 70.7%, and for the unselected original grouped
cases it was 71.3% correct. The classiﬁcations of the
selected cases tested by cross-validation showed that
70.2% of these classiﬁcations were correct.
The contribution of each variable to the model is
shown in table 11; 11 of the variables entered contribu-
ted to the model, while age, source of referral and
reason for end of IAPT care pathway were omitted. The
variables that had the most effect on the Treatment
Outcome were, in order of importance, PHQ9 and
GAD-7 1st scores, followed by DNA, number of attended
sessions, IMD and ethnicity. The length of treatment,
CBT, understanding of written English, Guided
Self-Help and gender, although contributing, were of
least effect.
Outcome group 3: can positive, partial and negative treatment
outcomes be predicted from pre-treatment variables?
Discriminant Analyses for Outcome Group 3 data (dif-
ferentiate between P1P2, P1N2, N1P2 and N1N2) using
the eight pre-treatment variables: gender, age, ethnicity,
understand written English, source of referral, PHQ-9 ﬁrst
score, GAD-7 ﬁrst score and IMD showed that Treatment
Outcome (P1P2, P1N2, N1P2 and N1N2) could be cor-
rectly predicted for between 38.9% and 56.3% of cases,
table 12. These results are no better than that obtained
by chance and are not acceptable. Therefore, although
it is possible to produce a model that will discriminate
between positive and negative Treatment Outcomes, it is
not possible to distinguish between the partial and total
negative Treatment Outcomes using the variables avail-
able at enrolment.
Table 6 Outcome Group 1 classification results for predictive model created using pre-treatment variables
Classification results
Treatment outcome
P1P2 vs N1N2
Predicted group membership
Total (%)P1P2 (%) N1N2 (%)
Cases selected
Original (71.8%) P1P2 69.9 30.1 100.0
N1N2 25.9 74.1 100.0
Cross-validated (71.6%) P1P2 69.9 30.1 100.0
N1N2 26.2 73.8 100.0
Cases not selected
Original (74.9%) P1P2 73.9 26.1 100.0
N1N2 24.0 76.0 100.0
GAD7, Generalised Anxiety Disorder-7; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; P1P2, positive
PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.
Table 7 Contributions of individual pre-treatment
variables to the model created to predict outcomes for the
model for predicting outcomes within Outcome Group 1
Tests of equality of group means
Order of
Importance Variables Wilks’ λ Significance
1 PHQ-9 first 0.794 <0.001
2 GAD-7 first score 0.823 <0.001
3 Caseness
achieved
0.849 <0.001
4 IMD 0.976 <0.001
5 Ethnicity 0.987 <0.001
6 Age 0.995 0.005
7 Source of referral
(coded)
0.996 0.010
8 Gender 0.997 0.039
9 Understand
written English?
0.998 0.058
GAD7, Generalised Anxiety Disorder-7; IMD, Index of Multiple
Deprivation; PHQ9, Patient Health Questionnaire-9.
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Comparing the results when data from Service A or
Service B was used to classify the Treatment Outcome,
2532 cases of the 3830 (66.1%) in the database gave
identical results. This is acceptably close to the overall
percentage of cases correctly classiﬁed, justifying
merging the data from the two services. The model is
therefore robust enough to allow calculations on data
from one service to be made using a model based on
another service.
DISCUSSION
The analysis identiﬁed initial severity of anxiety and
depression, ethnicity, deprivation and gender as pre-
treatment predictors of recovery. The study also demon-
strates the importance of the duration of treatment as
seen by the relationship between number of sessions
attended/missed and recovery. The predictive models
developed were able to assign a positive or negative clin-
ical outcome to each patient based on these ﬁve inde-
pendent pre-treatment variables, with an accuracy of
69.4% and 79.3%, respectively. The assessment of com-
pleteness of data collection has established the accuracy
with which analysis of IAPT data can be undertaken,
and the feasibility and necessity of undertaking larger
scale analysis of population data to speciﬁcally assess the
situation for recovery of those from BME groups, areas
of deprivation and, importantly, further understand the
reasons why a signiﬁcant number of patients ‘drop out’
from the service.
All IAPT services in England collect, collate and
analyse patient-level data to provide individualised feed-
back to patients on progress and monitor service per-
formance. Despite the availability of this rich data set,
very little work has been done to explore the factors
associated with why some people recover following treat-
ment within the IAPT service and others do not. It is
likely to become increasingly important for individual
IAPT services to understand their own patient and
service/treatment characteristics associated with
enhanced recovery rates, to ensure continued outcomes,
funding and support, as targets for recovery increase.
Understanding how the potential differences in local
population composition could impact on outcomes will
also help understand differences on key performance
indicators between IAPT services.
Gyani et al18 published a report summarising recovery
rates and their predictors across 32 IAPT sites during the
ﬁrst year of their operation. A multivariate logistic
regression found that a number of determinants were
signiﬁcantly associated with the likelihood of recovery
across sites. First, greater numbers of therapy sessions
were associated with higher recovery rates. Second,
severity of initial symptoms had a negative impact on
likelihood of recovery; the higher the initial PHQ-9 and
GAD-7 scores, the less likely a patient was to achieve
recovery. Third, experience/seniority of therapists had
an impact on likelihood of recovery, with higher levels of
experience/seniority associated with more successful
outcomes. While Gyani et al18 provide some insights
echoed by the current analysis, patient-level character-
istics such as age, sex, ethnicity and language ability,
were not included in their analysis of predictors of
outcome.
Table 8 Outcome Group 2 classification results for predictive model created using pre-treatment variables
Classification results
Treatment outcome
P1P2 vs 3 other groups merged
Predicted group membership
Total (%)P1P2 (%) N and partial N (%)
Cases selected
Original (68.5%) P1P2 67.2 32.8 100.0
P1N2, N1P2 and N1N2 30.3 69.7 100.0
Cross-validated (68.3%) P1P2 66.8 33.2 100.0
P1N2, N1P2 and N1N2 30.4 69.6 100.0
Cases not selected
Original (70.9%) P1P2 71.0 29.0 100.0
P1N2, N1P2 and N1N2 29.3 70.7 100.0
GAD7, Generalised Anxiety Disorder-7; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; P1P2, positive
PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.
Table 9 Contributions of individual pre-treatment
variables to the model created to predict outcomes for the
model for predicting outcomes within Outcome Group 2
Tests of equality of group means
Order of
importance Variable Wilks’ λ Significance
1 PHQ-9 first score 0.846 <0.001
2 GAD-7 first score 0.858 <0.001
3 IMD 0.986 <0.001
4 Ethnicity 0.992 <0.001
5 Understand
written English?
0.998 0.036
6 Gender 0.999 0.045
7 Age 0.999 0.077
GAD7, Generalised Anxiety Disorder-7; IMD, Index of Multiple
Deprivation; PHQ9, Patient Health Questionnaire-9.
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The ﬁndings from this study, similar to that of Gyani
et al18, show that the more sessions a patient received,
the more likely they were to recover. Also, that initial
symptom severity had a negative impact on likelihood of
recovery, the higher the initial PHQ-9 and GAD-7 scores,
the less likely a patient was to achieve recovery. Gyani
et al18 suggests that this is an artefact of the way that
recovery is deﬁned, as, in fact, IAPT services can offer
beneﬁts to patients across a spectrum of severity.18
Previous studies have also reported that while psycho-
logical therapies can demonstrate an improvement in
clinical outcomes, more than eight sessions achieve a
greater positive response, in those with anxiety at least.19
Furthermore, this study has demonstrated that it is
possible to develop a robust model based on discrimin-
ant analysis that is accurate in predicting the outcome of
patients given the speciﬁc independent variables prior
to the start of treatment. While the model is able to suc-
cessfully discriminate those patients with a positive
outcome (P1P2) from those with a negative outcome
(N1N2), it was less accurate in distinguishing those
patients who achieved a positive outcome in either
PHQ-9 or GAD-7 scores alone (P1N2 or N1P2). Factors
identiﬁed that were associated with outcome were sever-
ity of disease on entry (initial PHQ-9 and GAD-7 scores),
ethnicity, socioeconomic status (IMD) and gender.
Analysis of data has demonstrated a high level of com-
pletion with an average of 93.2% completion rate for
the data ﬁelds.
The effect of factors including ethnicity and gender
on clinical outcomes following treatment of CMD with
psychological therapies in the literature is scant or con-
ﬂicting. There seems to be a dearth of studies that have
speciﬁcally aimed to assess the effect of these demo-
graphic factors on outcomes.20 Our group has previously
demonstrated an association between socioeconomic
status and severity of illness; while that study demon-
strated the ability for patients from deprived areas to
achieve similar outcomes as those from less deprived
areas, this was in response to a programme of activity tar-
geted at this population.21 Socioeconomic status, as
assessed by educational attainment and income, was also
demonstrated to be associated with greater improve-
ments in clinical outcomes.22
Referral rates in the study are similar to those
reported elsewhere with females accounting for 61%,
and those classed as white British accounting for
37.6%.18 23 The well described link between prevalence
in CMDs and deprivation is noted in the reduced likeli-
hood of a positive treatment outcome in patients from
areas of higher deprivation.4 24 While deprivation has
been shown to be associated with outcomes, the effect
may well be underestimated.
Table 10 Outcome Group 2 classification results for predictive model created using pre-treatment and post-treatment
variables
Classification results
Treatment outcome
P1P2 vs 3 other groups merged
Predicted group membership
TotalP1P2 (%) N and partial N (%)
Cases selected
Original (70.7%) P1P2 71.4 28.6 100.0
P1N2, N1P2 and N1N2 30.0 70.0 100.0
Cross-validated (70.2%) P1P2 70.9 29.1 100.0
P1N2, N1P2 and N1N2 30.4 69.6 100.0
Cases not selected
Original (71.3%) P1P2 69.3 30.7 100.0
P1N2, N1P2 and N1N2 26.8 73.2 100.0
GAD7, Generalised Anxiety Disorder-7; N1N2, negative PHQ-9, negative GAD-7; N1P2, negative PHQ-9, positive GAD-7; P1P2, positive
PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.
Table 11 Contributions of individual pre-treatment and
post-treatment variables to the model created to predict
outcomes for the model for predicting outcomes within
Outcome Group 1
Tests of equality of group means
Order of
importance Variables Wilks’ λ Significance
1 PHQ9 1st score 0.842 <0.001
2 GAD7 1st score 0.865 <0.001
3 No. DNA sessions 0.974 <0.001
4 No. attended
sessions
0.981 <0.001
5 IMD 0.987 <0.001
6 Ethnicity 0.992 <0.001
7 Length of
treatment in days
0.998 0.041
8 Cognitive–
behavioural
therapy
0.998 0.037
9 Understand
written English?
0.998 0.057
10 Guided self help 0.999 0.077
11 Gender 0.999 0.087
GAD7, Generalised Anxiety Disorder-7; IMD, Index of Multiple
Deprivation; PHQ9, Patient Health Questionnaire-9.
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Attrition has previously been shown to be linked to
deprivation suggesting that patients from areas of higher
deprivation are more likely to ‘drop out’ of the service,
and thus potentially excluded from the analysis.25
Our previous study of a subset of the data demon-
strated that patient outcomes were similar across all
deprivation groups, although that analysis used PHQ-9
as the sole outcome measure.21
Limitations of this study
A proportion of the patients were excluded from the study
due to incomplete data for certain independent variables
of interest. Imputation was not considered appropriate to
recover these exclusions, as we had no speciﬁc data to
provide ‘average’ values. Additionally, while the sample
size was sufﬁciently large to investigate the variables
included in the study, a larger study would allow subanaly-
sis of variables and their interactions with each other
including factors such as different ethnicity categories and
intensity/mode of treatment. Importantly, a signiﬁcant
population of patients who were referred to the service
have been excluded from the analysis, those who do not
complete treatment, that is, those who ‘dropped out’. It is
clear that it is extremely important to understand the
reasons why this group does not complete treatment,
although this methodology may have limitations in accur-
ately characterising this population. The authors are cur-
rently undertaking a larger study to ensure this important
subanalysis (including those who drop out) is undertaken
in collaboration with a larger number of services across
the northwest London area.
CONCLUSION
As De Lusignan et al23 has demonstrated, people with
CMDs have a higher rate of healthcare resource utilisa-
tion than those without CMDs, and IAPT referral can
actively reduce this along with a reduction in sickness
reporting, as was intended by the programme. While
previous studies have demonstrated a range of interven-
tions that can be harnessed to increase access to
IAPT services, more needs to be done to tailor
treatment to improve the outcomes of individuals.21 26 27
Interventions and treatment moderators should be iden-
tiﬁed that improve support and engagement for those
‘at risk’ of not achieving a positive outcome following
treatment. Identifying patients at risk of achieving poor
outcomes at entry offers an opportunity to provide
enhanced support for this group, which might include
the further development of culturally sensitive services
or additional support relevant to those living in deprived
areas, including better access through improvements in
transport or patient incentives to encourage attendance.
Further studies should be developed to speciﬁcally
investigate the exact nature and extent to which depriv-
ation inﬂuences clinical outcomes, and potential inter-
ventions developed to ameliorate any negative effect.
While there is some evidence of an increased prevalence
of CMDs in some BME groups, a more detailed analysis
would be required to dissect out the individual ethnic
groups from ‘BME’ and cross-link this data with informa-
tion on deprivation or communication skills to ensure a
more sophisticated characterisation of the population,
not just a typology based on one characteristic such as
ethnicity.
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Table 12 Outcome Group 3 classification results for predictive model created using pre-treatment variables
Classification results
Treatment outcome
4 choices
Predicted group membership
TotalP1P2 P1N2 N1P2 N1N2
Cases selected
Original P1P2 40.4 23.7 20.4 15.5 100.0
P1N2 22.5 42.6 9.3 25.6 100.0
N1P2 19.1 9.2 40.5 31.3 100.0
N1N2 9.5 19.8 18.5 52.2 100.0
Cross-validated P1P2 40.2 23.8 20.4 15.5 100.0
P1N2 22.5 42.2 9.3 26.0 100.0
N1P2 20.6 9.2 38.9 31.3 100.0
N1N2 9.5 20.1 18.7 51.7 100.0
Cases not selected
Original P1P2 40.8 24.4 19.8 15.0 100.0
P1N2 21.9 47.9 11.5 18.8 100.0
N1P2 17.2 6.3 56.3 20.3 100.0
N1N2 11.4 18.3 19.6 50.7 100.0
GAD7, Generalised Anxiety Disorder-7; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; P1P2, positive
PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.
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